Neurotherapeutic Potential of Water-Soluble pH-Responsive Prodrugs of EIDD-036 in Traumatic Brain Injury.
Russell G FritzemeierAletta E van der WesthuyzenMichael D'ErasmoSavita K SharmaPerry BartschLuke E HodsonKen LiuBushra WaliIqbal SayeedCourtney C AldrichPublished in: Journal of medicinal chemistry (2023)
The C-20 oxime of progesterone, EIDD-036 ( 2 ), demonstrates neuroprotection and improved outcomes in animal models of traumatic brain injury (TBI). However, 2 suffers from poor solubility, which renders it unsuitable for rapid administration. Previous prodrugs of 2 aimed at improving solubility by incorporating enzymatically labile amino acid and phosphate ester promoieties. These approaches were effective but led to limitations with in vivo administration. Herein, we disclose a pH-responsive water-soluble prodrug strategy to improve exposure to 2 through enzyme-independent activation. Compound 13l was identified as a lead that exhibits water-solubility, stability in acidic solutions, and rapid conversion to 2 at physiological pH. Administration of 13l to rats resulted in a twofold increase in exposure to 2 compared to the previous generation phosphate prodrug, EIDD-1723 ( 6 ). In a rat model of TBI, treatment with 13l resulted in a significant decrease in cerebral edema when administered postinjury.